Phage Therapy - Part B

Prof. Vijai Singh is currently serving as Head of the Department of Biosciences, School of Science and Dean (Research & Innovation) at Indrashil University, Rajpur, Mehsana, India. Prior to this, he held the position of Associate Professor in the same department at Indrashil University. He has also served as Assistant Professor in the Department of Biological Sciences and Biotechnology at the Institute of Advanced Research, Gandhinagar, and in the Department of Biotechnology at the Invertis University, Bareilly, India. Earlier of his career, Prof. Singh worked as a Postdoctoral Fellow in the Synthetic Biology Group at the Institute of Systems and Synthetic Biology, Paris, France and at the School of Energy & Chemical Engineering at the Ulsan National Institute of Science and Technology, Ulsan, South Korea. He earned his Ph.D. in Biotechnology in 2009 from the ICAR-National Bureau of Fish Genetic Resources, Uttar Pradesh Technical University, Lucknow, India. His doctoral research focused on the development of molecular and immunoassays for the diagnosis of Aeromonas hydrophila. Prof. Singh’s research interests lies in the design and construction of novel biosynthetic pathways for production of medically and industrially important biomolecules. His laboratory is also actively engaged in developing CRISPR-Cas systems for gene knock out, knock in, gene regulation and diagnostic. With over 15 years of research and teaching experience, his areas of expertise include synthetic biology, metabolic engineering, bioinformatics, microbiology, and industrial microbiology. He has an extensive academic record, with over 110 articles, 89 book chapters, 26 books and 3 patents to his credits. Prof. Singh has received number of prestigious awards, including the Bioclues Innovation, Research and Development Award (2023) from the BIOCLUES Society, the Vice Chancellor's Best Research Award (2023) from Indrashil University, and the Agathiyar Chemical Biology Award (2023) from the Society of Chemical and Synthetic Biology. At Indrashil University, he currently serves as chairman of the Board of Study, and is a member of the Academic Council of Indrashil University. He also holds the position of the Member Secretary of the Institutional Biosafety Committee (IBSC) at the university. Dr. Singh is actively involved in national and international scientific advisory roles.

• 1. Phages for treatment Pseudomonas aeruginosa infectionSalsabil Makky, Fatma Abdelrahman, Nouran Rezk, Maheswaran Easwaran, and Ayman El-Shibiny2. Phage for treatment of Vibrio cholerae infectionMilky Mittal, Surbhi Tripathi, Ashok Saini, and Indra Mani3. Phages for the treatment of Mycobacterium speciesChristoffel Johannes Opperman, Justyna Wojno, Wynand Goosen, and Rob Warren4. Phage therapy in gut microbiomeXingyao Chen, Beatriz G. Mendes, Bruno Secchi Alves, and Yi Duan5. Phages as delivery vehicles and phage displaySalsabil Makky, Fatma Abdelrahman, Maheswaran Easwaran, Anan Safwat, and Ayman El-Shibiny6. Unlocking the potential of phages: Innovative approaches to harnessing bacteriophages as diagnostic tools for human diseasesVishnu Kirthi Arivarasan7. Phage Display and Human Disease DetectionSonu Kumari, Krati Singh, Neha Singh, Suphiya Khan, and Ajay Kumar8. Bacteriophage as cargo and its application in nanomedicineVishnu Kirthi Arivarasan and Chitrakshi Consul 9. Phage for drug delivery vehiclesMohit Kumar, Piyush Parkhey, Santosh Kumar Mishra, Prabir Kumar Paul, Avinash Kumar Singh, and Vijai Singh10. Genome editing for phage design and uses for therapeutic applicationsKarthik Loganathan and Baskaran Viswanathan11. Phage for cancer therapyHue Vu Thi, Anh-Dao Ngo, Linh-Thao Tran, and Dinh-Toi Chu12. Phage for regenerative medicine and cosmeticsNhat-Le Bui, Mai Anh Nguyen, Manh-Long Nguyen, Quoc-Cuong Bui, and Dinh-Toi Chu